glp 1 alzheimer's 2024 🧐Will GLP-1RA drugs be the future of altzeimers treatement? 🧠There are multiple studies underway assessing the effectiveness of glp-1 class of medications in prevention and/or delay of dementia 🧠Alzheimer's makes up 60%-80% Long-awaited results of GLP-1 trial

Cardiovascular outcome trials (CVOTs) in people living with type 2 diabetes mellitus and obesity have confirmed the cardiovascular benefits of glucagon-like peptide 1 receptor agonists (GLP-1RAs), including reduced cardiovascular mortality, lower ...

Partially hydrolyzed guar gum (Sunfiber)

Learn what it is, why people are trying it to lower side effects and cost, and how to do it safely, effectively, step by step.

Ultrasound assessments could improve risk stratification for perioperative management

Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February.

GLP-1 drugs, which include Ozempic and Wegovy, have becomeone of the most closely watched experimental approachesfor slowing Alzheimers a disease with few treatment options.